Company Overview and News
Not to be outdone by our own initiatives regarding legal marijuana, Canada stepped up as the first G7 nation to approve recreational weed. Our northern neighbor’s upper chamber voted 52 to 29 favoring Bill C-45, a proposal to overturn a multi-year cannabis ban.
TWMJF ACB NXTTF WEED ACBFF CGC
BOSTON, MA / ACCESSWIRE / June 4, 2018 / Digital Utilities Ventures, Inc. (OTC PINK: DUTV), an emerging seed to sale player in the growing legal cannabis marketplace, today announces it has entered into an auditing agreement with PCAOB accounting firm Boyle CPA, LLC Certified Public Accountants 361 Hopedale Drive SE P Bayville, NJ 08721Boyle CPA, LLC. Digital will be filing full audited financial for the fiscal year ending May 31, 2018.
NXTTF DUTV CANN
VANCOUVER, British Columbia, May 14, 2018 (GLOBE NEWSWIRE) -- Namaste Technologies Inc. (“Namaste” or the “Company”) (TSXV:N) (FRANKFURT:M5BQ) (OTCMKTS:NXTTF) is pleased to announce the integration of several critical updates to the Company’s online patient acquisition tool, NamasteMD Inc. (“NamasteMD”). NamasteMD, which is the Company's revolutionary mobile app, which is available on desktop, Apple IOS and Android devices, has allowed Namaste to accelerate patient growth at a rate that exceeds any industry peers and at significantly lower cost per patient.
TORONTO, May 11, 2018 (GLOBE NEWSWIRE) -- BELGRAVIA CAPITAL INTERNATIONAL INC. (CSE:BLGV) (OTCQB:BLGVF) (“Belgravia” or the “Company”) today announced that it has completed the strategic transition of ICP Organics, the fully owned subsidiary of Belgravia, to a cannabinoid-based dermatology ethical drug research and product development company. Further, the name of ICP Organics, the dermatology division of Belgravia, is being changed to Belgravia Dermatology Inc.
BLGVF NXTTF ICPTF ICP
VANCOUVER, British Columbia, May 10, 2018 (GLOBE NEWSWIRE) -- Namaste Technologies Inc. (“Namaste” or the “Company”) (TSXV:N) (FRANKFURT:M5BQ) (OTCMKTS:NXTTF) is pleased to announce that further to the April 5th announcement of an LOI with 2624078 Ontario Inc., the Company has signed a Share Purchase Agreement (“SPA”) to acquire 51% of the outstanding shares of 2624078 Ontario Inc. (“Infinite Labz”) and has agreed to finance the construction of Infinite Labz’s facility in Etobicoke, Ontario.
Where the portfolio stood at the time of my last update, where it stands today and recent developments on the stocks held therein.
FB DB FFRMF ACBFF CGNX SW NVDA SWIR SHLD SWKS TWMJF WEED AAPL WELL CCI.PRA CCI ATT SNNVF ATTBF NXTTF STM ACB V FTMDF GOOGL JNJ MU TSLA MSFT SHLDW APHQF
TORONTO, May 09, 2018 (GLOBE NEWSWIRE) -- Apogee Opportunities Inc. (“Apogee” or the “Company”) (TSXV:APE) and ANM, Inc. (“Halo”) (doing business as Halo Labs) are pleased to announce that they have entered into a binding letter of intent (“LOI”) to complete a business combination transaction (the “Transaction”). Upon completion of the Transaction, the combined entity (the “Resulting Issuer”) will continue to carry on the business of Halo.
NXTTF GLH GLDFF
VANCOUVER, British Columbia, May 07, 2018 (GLOBE NEWSWIRE) -- Namaste Technologies Inc. (“Namaste” or the “Company”) (TSXV:N) (FRA:M5BQ) (OTCMKTS:NXTTF) is pleased to announce that the Company has signed an exclusive drop-shipping supply agreement (the “Agreement”) with Ample Organics Inc. (“Ample Organics”). Ample Organics is Canada’s leading seed-to-sale software platform, currently used by the majority of Canada’s licensed producers of medical cannabis (“LPs”).
Management has a well-documented history of failure coupled with repeated misses on their financial/operational targets; CEO used to be in the knock-off purse business.
TWMJF ACB NXTTF MJNA WEED ACBFF MJN PRMCF
VANCOUVER, British Columbia, May 02, 2018 (GLOBE NEWSWIRE) -- Namaste Technologies Inc. (“Namaste” or the “Company”) (TSX-V:N) (FRA:M5BQ) (OTCMKTS:NXTTF) is pleased to announce that on May 1, 2018 the Company executed a definitive agreement to acquire (the “Acquisition”) all of the issued and outstanding shares of Findify AB (a Swedish corporation, “Findify”), for a purchase price of US $12,000,000 in a combination of cash and common shares of the Company.
VANCOUVER, British Columbia, May 01, 2018 (GLOBE NEWSWIRE) -- Namaste Technologies Inc. (“Namaste” or the “Company”) (CSE:N) (FRA:M5BQ) (OTCMKTS:NXTTF) is pleased to announce that the Company has received final approval to list the common shares and warrants of the Company on the TSX Venture Exchange (“TSXV”) as a Tier 1 issuer. The common shares and warrants of the Company will be delisted from the Canadian Securities Exchange at the close of trading on May 1, 2018 and listed on the TSXV at the opening of trading on May 2, 2018.
VANCOUVER, British Columbia, April 25, 2018 (GLOBE NEWSWIRE) -- Namaste Technologies Inc. (“Namaste” or the “Company”) (CSE:N) (FRA:M5BQ) (OTCMKTS:NXTTF) is pleased to announce that it has signed a non-binding letter of intent (“LOI”) with Pineapple Express Delivery Inc. (“Pineapple Express”), whereby Namaste will invest $1,000,000 to acquire 15% of the share capital of Pineapple Express and obtain a right of first refusal to purchase an additional 10% of the share capital for an additional $1,200,000.
VANCOUVER, British Columbia, April 19, 2018 (GLOBE NEWSWIRE) -- Namaste Technologies Inc. (“Namaste” or the “Company”) (CSE:N) (FRA:M5BQ) (OTCMKTS:NXTTF) is pleased to announce that it has received conditional approval to list the common shares and warrants of the Company on the TSX Venture Exchange (“TSXV”) as a Tier 1 issuer. The listing is subject to the Company fulfilling certain requirements of the TSXV in accordance with the terms of its conditional approval letter dated April 18th, 2018.
2018-02-04 - Asif
Namaste is the largest online retailer for medical cannabis delivery systems globally. Namaste distributes vaporizers and smoking accessories through e-commerce sites in 26 countries and with 5 distribution hubs located around the world. Namaste has majority market share in Europe and Australia, with operations in the UK, Canada and Germany and has opened new supply channels into emerging markets including Brazil, Mexico and Chile. Namaste, through its acquisition of Cannmart Inc., a Canadian based late-stage applicant for a medical cannabis distribution license (under the ACMPR Program) is pursuing a new revenue vertical in online retail of medical cannabis in the Canadian market. Namaste intends to leverage its existing database of Canadian medical cannabis consumers, along with its expertise in e-commerce to create an online marketplace for medical cannabis patients, offering a larger variety of product and a better user experience. Description of the business Dollinger E...
2018-07-17 - Asif
History and Development of the Company Kitov Pharma was incorporated under the laws of the State of Israel (under a previous name) on August 12, 1968 and its ordinary shares were originally listed for trading on the TASE in 1978. The company's ordinary shares are currently traded on the TASE under the symbol “KTOV”, and its ADSs and its public warrants are traded on NASDAQ under the symbols “KTOV” and “KTOVW”, respectively. In October 2012, the District Court in Lod, Israel approved the creditors arrangement in accordance with Section 350 of the Companies Law in order to effectuate the sale by Kitov Pharma (then known as Mainrom Line Logistics Ltd.) of all its activities, assets, rights, obligations and liabilities to a private company held by its then controlling shareholders, and all rights of Kitov Pharma’s creditors against it were extinguished. The sale was made pursuant to an arrangement between Kitov Pharma and its creditors. Following such sale and a related cash...
2018-07-17 - Asif
Overview and Recent Developments Athersys is an international biotechnology company that is focused primarily in the field of regenerative medicine. The company's MultiStem® cell therapy, a patented and proprietary allogeneic stem cell product, is its lead platform product and is currently in later-stage clinical development. The company's current clinical development programs are focused on treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, certain pulmonary conditions and other conditions where the current standard of care is limited or inadequate for many patients, particularly in the critical care segment. Current Programs By applying its proprietary MultiStem cell therapy product, the company established therapeutic product development programs treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, and other conditions. The company's programs in the clinical development stage include ...
2018-07-16 - Asif
General The company's objective is to build a profitable and growing specialty therapeutics company. To meet this objective, Cytori Therapeutics has acquired and are developing two technology platforms that hold promise for treating millions of patients and represent significant potential for increasing shareholder value. The company's current corporate activities fall substantially into advancing these platforms: Cytori Nanomedicine and Cytori Cell Therapy. The Cytori Nanomedicine platform features a versatile liposomal nanoparticle technology for drug encapsulation that has thus far provided the foundation to bring two promising drugs into mid/late stage clinical trials. Nanoparticle encapsulation is promising because it can help improve the delivery and metabolism of many drugs, thus potentially enhancing the therapeutic profile and patient benefits. The company's lead drug candidate, ATI-0918 is a generic version of pegylated liposomal encapsulated doxorubicin. Pegyl...
as of ET